Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

News in brief

EWP says manufacturing line at West African firm operational soon

23-Mar-2010 - A Ghanian drugmaker will soon start producing generic pharmaceuticals for the West African market, according to investment group Emerging World Pharma.

News in brief

US drug sector increased R&D spending 2% in 2009

18-Mar-2010 - US pharmaceutical and biotechnology firms spent a record $65bn (€48bn) on drug and vaccine R&D in 2009, says a new study by the Pharmaceutical Research and Manufacturers of America (PhRMA)...

Irish pharma sector must attract R&D to secure competitve edge, says PCI

18-Mar-2010 - Ireland must become an R&D hub as well as a drug manufacturing destination to prosper in the increasingly competitive global pharmaceutical market, says industry body PharmaChemical Ireland (PCI).

Prosonix launches UMAX particle tech for respiratory drugs

17-Mar-2010 - Prosonix’ new UMAX particle engineering technology is set to “revolutionise” the field of respiratory medicines, according to company CEO David Hipkiss.

FDA wants more data on Afrezza's "clinical utility"; MannKind's shares fall

16-Mar-2010 - US Food and Drug Administration (FDA) request for more Afrezza data is not safety related and will not require new clinical trials, says developer MannKind.

Sigma adds big name small molecules to portfolio in Pfizer deal

15-Mar-2010 - Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major...

News in brief

AstraZeneca to sell branded generics in deal with Torrent

15-Mar-2010 - AstraZeneca targets global generics market in license and supply deal with Indian manufacturer Torrent Pharma.

FDA OK for Haupt Pharma’s Italian antibiotics plant

01-Mar-2010 - US FDA clearance for Italian antibiotics production facility is important for global growth says German contract development and manufacturing organisation (CDMO) Haupt Pharma.

Aptuit unveils new solid state chemistry screen

18-Feb-2010 - US group Aptuit has bolstered its chemistry offering with a new solid state chemistry screen that it says will enable better decisions during drug formulation development and process scale-up.

Merck & Co to reduce workforce 15%

17-Feb-2010 - Merck & Co says manufacturing and R&D jobs will go as part of the post acquisition workforce reduction programme it announced yesterday.

Sohm: deal is boost for capacity and profitability

11-Feb-2010 - Generics firm Sohm says deal with manufacturer in Himachal Pradesh doubles capacity, cuts costs 6 per cent and increases profitability.

Deals dominate developments in drug delivery space

02-Feb-2010 - In-PharmaTechnologist presents a round up of recent developments in the field of drug delivery, with new deals for Starpharma and Penwest, and a regulatory filing for Hovione.

Watson buys Eden Biodesign

01-Feb-2010 - US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.

AZ plans 8,000 job cuts by 2014 and will outsource more R&D

29-Jan-2010 - AstraZeneca will cut 8,000 more jobs by 2014 with R&D and supply chain operations being the main focus of the cutbacks.

Crospon spins out transdermal patch

28-Jan-2010 - Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further...

LTS teams up with IntelGenx on VersaFilm

26-Jan-2010 - LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.

Lupin's Mandideep plant OKed by US FDA

21-Jan-2010 - Indian drugmaker Lupin can start seeking US approval for new drugs made at its API plant in Mandideep, Bhopal after resolving the cGMP deficiencies that earned the facility a US...

Access’ oral insulin shows preclinical promise

20-Jan-2010 - Access Pharmaceuticals’ insulin diabetes treatment has shown promise in preclinical trials, achieving over 80 per cent oral bioavailability, leading the company to target proof-of-concept studies in humans.

Vaccine market worth $52bn in 2016

18-Jan-2010 - Global vaccine revenues will be $52bn (€36.2bn) in 2016, more than double the total for 2009, driven by new products and indication expansions of established therapies, according to a report.

Lonza to close Riverside API plant

14-Jan-2010 - Lonza will shut down its API plant in Riverside, Pennsylvania, US by the end of the year as part of a plan to cut costs and shift small-molecule production to...

GSK to shift Avodart production to Poland in 2011

11-Jan-2010 - GSK says it will start making its BPH drug Avodart (dutasteride) at its facility in Poznan, Poland when it completes a PLN70m (€17m) capacity upgrade in January next year.

Luitpold buys PharmaForce for generic injectables

07-Jan-2010 - Daiichi-Sankyo subsidiary Luitpold Pharmaceuticals has acquired PharmaForce, giving it a 40,000 sq ft cGMP compliant sterile manufacturing facility and a 20,000 sq ft API production plant.

Next step towards generics, Pfizer teams with Strides

07-Jan-2010 - Pfizer will soon sell more generic pharmaceuticals in the US after its agreement with Indian non-branded drugmaker Strides Arcolab.

News in brief

CyDex awarded additional Captisol patent

06-Jan-2010 - The US PTO has granted CyDex new patent for the production of ultra high-purity modified cyclodextrin.

Ranbaxy sells China JV and changes strategy

05-Jan-2010 - Ranbaxy Laboratories has sold its Chinese JV, Ranbaxy Guangzhou China Limited (RGCL), as part of a new approach to the country’s rapidly expanding drug market.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...